Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women

J Infect Dis. 2004 Nov 1;190(9):1575-85. doi: 10.1086/424854. Epub 2004 Sep 29.

Abstract

Background: Genetic polymorphism in human papillomavirus (HPV)-33 and -35 was investigated in 1055 sexually active women (732 human immunodeficiency virus [HIV] seropositive and 323 HIV seronegative).

Methods: Consecutive genital specimens obtained at 6-month intervals were screened for HPV-33 and -35 by use of MY09-MY11. HPV-33 and -35 isolates from 95 women were analyzed by polymerase chain reaction sequencing of the long control region (LCR), E6, and E7.

Results: For HPV-33, 101 (20%) of 506 nucleotides in the LCR were variable, compared with 10 (2.1%) of 483 nucleotides in E6 (P<.001) and 6 (1.9%) of 324 nucleotides in E7 (P<.001). For HPV-35, the proportion of variable nucleotide sites was similar between the LCR and both E6 (P=.54) and E7 (P=.33). The presence of a 78-base pair deletion in HPV-33 (relative risk [RR], 1.8 [95% confidence interval [CI], 1.2-2.7]) and the presence of nonsynonymous E7 variations in HPV-35 (RR, 2.6 [95% CI, 1.4-4.6]) were associated with persistence. When the data for HPV-33 and -35 were combined, infection by HPV isolates with nonsynonymous E7 variations (RR, 2.3 [95% CI, 1.6-3.4]; P=.001) and ethnicity (P=.04) were associated with persistence, whereas age (P = .14) and HIV infection/CD4 cell count status (P=.12) were not significantly associated with persistence, by logistic regression analysis.

Conclusion: HPV-33 and -35 polymorphism was different between types and was associated with persistence of HPV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • DNA, Viral / chemistry
  • DNA, Viral / genetics
  • DNA, Viral / isolation & purification
  • Female
  • Genotype
  • HIV Seropositivity
  • Humans
  • Molecular Epidemiology
  • Oncogene Proteins, Viral / genetics
  • Papillomaviridae / genetics*
  • Papillomaviridae / isolation & purification
  • Papillomavirus Infections / virology*
  • Point Mutation
  • Polymorphism, Genetic*
  • Sequence Analysis, DNA
  • Sequence Deletion
  • Time Factors
  • Uterine Cervical Diseases / virology*
  • Vaginal Diseases / virology*

Substances

  • DNA, Viral
  • E7 protein, Human papillomavirus type 33
  • Oncogene Proteins, Viral